Skip to evidence report

MAC.MDM.complement_resolving: Studies

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,931 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 1–1,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for MAC.MDM.complement_resolving
#Trait / studyIndividual trait IDMean IC score
1TREM2 levelsGCST9047096078.95
2ALB levelsGCST9049710870.53
3CD83/TREM2 ratioGCST9031390866.50
4ADGRE2/B4GALT1 ratioGCST9031317466.14
5Recent trouble relaxing | AnxietyUKBB0000074565.68
6Urine andro steroid monosulfate C19H28O6S (1)* levels in chronic kidney diseaseGCST9026479664.57
7MELTF levelsGCST9046988563.59
8CPVL levelsGCST9046884861.74
9PIK3IP1/TNFRSF1A ratioGCST9031565359.99
10ALB levelsGCST9049710157.90
11CDCP1/MSR1 ratioGCST9031393855.88
12ITGA5 levelsGCST9046963554.41
13ALB levelsGCST9047510354.00
14ADGRE2/IFNGR1 ratioGCST9031317753.47
15IGSF21 levelsGCST9046953852.95
16ADA2/VCAM1 ratioGCST9031316752.19
17Aspartate aminotransferase levels (UKB data field 30650)GCST9046806351.95
18PSRC1/SORT1 ratioGCST9031574251.92
19CD83/HAVCR2 ratioGCST9031390451.74
20ALB levelsGCST9047510651.12
21Recent inability to stop or control worrying | AnxietyUKBB0000074250.95
22Aspartate aminotransferase (AST, minimum, inv-norm transformed)GCST9047512450.72
23Urine 16a-hydroxy DHEA 3-sulfate levels in chronic kidney diseaseGCST9026432950.02
24Triacylglycerol (52:4) [NL-16:0] levelsGCST9002517049.41
25Aspartate aminotransferase | Blood biochemistryUKBB0000005249.20
26HMOX1 levelsGCST9046946548.85
27AXL/MSR1 ratioGCST9031342248.79
28ALB levelsGCST9047510048.40
29PTPRZ1 levelsGCST9047038846.32
30CCL27 levelsGCST9046857946.21
31MARCO levelsGCST9046986145.94
32Cholesteryl esters to total lipids ratio in large LDLGCST9009285945.92
33HDL cholesterol levelsGCST9049734045.79
34CD300C/FOLR2 ratioGCST9031378745.12
35ALB levelsUKBB0000001945.12
36ADGRE2/CD58 ratioGCST9031317545.05
37CAMKK1/FOXO1 ratioGCST9031361345.00
38Phospholipids in large LDLGCST9049804944.74
39GOT1 levelsGCST9046937944.61
40Phospholipids in very large HDLGCST9050045144.33
41Total concentration of lipoprotein particlesGCST9050010344.04
42HPCAL1/PMVK ratioGCST9031507643.50
43CTSL levelsGCST9046891443.48
44CD164/LGMN ratioGCST9031374143.37
45ADGRE5/GAS6 ratioGCST9031317943.21
46Concentration of HDL particlesGCST9049740643.05
47Triglyceride to HDL cholesterol ratioGCST9029595043.00
48CD1C levelsGCST9046860442.86
49CRHBP/TREM2 ratioGCST9031426042.36
50CD74/JAM2 ratioGCST9031389342.28
51Plasma methylsuccinoylcarnitine levels in chronic kidney diseaseGCST9026550841.56
52Cholesteryl Esters in Large LDLGCST9049794941.48
53Total Lipids in HDLGCST9049740141.44
54Triglycerides in small HDLGCST9049951640.99
55CD300C/HAVCR2 ratioGCST9031378940.74
56LTBP2/PDGFRA ratioGCST9031533840.70
57Free Cholesterol to Total Lipids in Medium HDL percentageGCST9049858340.68
58APOA1 levelsGCST9049711940.62
59Cholesteryl Esters in HDLGCST9049735740.58
60CDCP1 levelsGCST9046866740.49
61MRC1 levelsGCST9046993940.48
62NRP2 levelsGCST9047008640.37
63Cholesteryl Esters to Total Lipids in Medium HDL percentageGCST9049855040.23
64HDL cholesterolGCST9001873640.07
65FGA levelsGCST9046921639.91
66ALB levelsGCST9026957639.89
67Cholesterol to Total Lipids in Small HDL percentageGCST9049936939.85
68Phospholipids to Total Lipids in Large HDL percentageGCST9049786839.81
69Free Cholesterol in HDLGCST9049737939.79
70MMP9/PLTP ratioGCST9031547139.78
71Concentration of large HDL particlesGCST9049783639.77
72IL27 levelsGCST9001201739.75
73Aspartate aminotransferase (AST, mean, inv-norm transformed)GCST9047512139.74
74HAVCR2/TREM2 ratioGCST9031503139.61
75Haematocrit percentage (UKB data field 30030)GCST9046807339.52
76COMP/ITGAV ratioGCST9031419039.33
77Cholesteryl Esters to Total Lipids in Small HDL percentageGCST9049940339.28
78MFGE8 levelsGCST9046990039.26
79Total lipids in large HDLGCST9049781839.23
80CCN2/MGLL ratioGCST9031371439.18
81Average diameter for HDL particlesGCST9049744639.16
82Total concentration of lipoprotein particlesGCST9050010139.14
83Cholesterol to Total Lipids in Medium HDL percentageGCST9049851939.02
84PLAUR/TREM2 ratioGCST9031567639.00
85CTSS levelsGCST9046891638.91
86Triglyceride levels in chylomicrons and extremely large VLDLGCST9050106838.67
87CD300C/LRRC25 ratioGCST9031379038.60
88Concentration of HDL particlesGCST9049741438.56
89Phospholipids in HDLGCST9049743038.51
90NCAM1 levelsGCST9047000338.46
91PLA2G15/PRCP ratioGCST9031566138.39
92ALB levelsGCST9009280738.36
93ALB levelsGCST9002599238.28
94HDL cholesterol levelsGCST9049735238.03
95PIK3IP1/TNFRSF1B ratioGCST9031565437.94
96Concentration of medium HDL particlesGCST9049861737.66
97Triglycerides in medium HDLGCST9049867237.65
98Free Cholesterol in HDLGCST9049738137.54
99CSPG4 levelsGCST9046889037.53
100Free Cholesterol to Total Lipids in Small HDL percentageGCST9049943137.36
101Total cholines levelsGCST9049718337.36
102GAS6/NOTCH1 ratioGCST9031491837.28
103PECAM1/SOD2 ratioGCST9031564737.23
104LILRA5 levelsGCST9046977437.08
105C1QA levelsGCST9046848536.97
106Cholesteryl Esters to Total Lipids in Large HDL percentageGCST9049776836.93
107Free Cholesterol to Total Lipids in Medium HDL percentageGCST9049858036.90
108CCL22 levelsGCST9046857436.88
109COLEC12/TNFRSF1A ratioGCST9031418736.87
110APOA1 levelsGCST9049712236.76
111High density lipoprotein cholesterol levelsGCST9023965136.69
112RHOC/TBCC ratioGCST9031577536.53
113Concentration of small HDL particlesGCST9049946136.46
114Aspartate aminotransferase (AST, maximum, inv-norm transformed)GCST9047511836.44
115Neutrophill count (UKB data field 30140)GCST9046809236.43
116Neutrophil countGCST9000235136.41
117NPTX2 levelsGCST9047007936.34
118FCAR/LY96 ratioGCST9031478836.28
119CD99/RELT ratioGCST9031393036.24
120Cholesteryl Esters in HDLGCST9049736836.18
121Phosphatidylcholine levelsGCST9049924836.15
122IGDCC4 levelsGCST9046952336.07
123APOA levelsGCST9046806135.99
124Free cholesterol in very large HDLGCST9050038335.97
125CD300E/LILRA5 ratioGCST9031379835.84
126CD40LG/EREG ratioGCST9031382035.83
127Total phospholipid levels in lipoprotein particlesGCST9050012435.72
128CCL11/CCL7 ratioGCST9031367335.64
129DPP4 levelsGCST9046903335.50
130Cholesterol to Total Lipids in Large HDL percentageGCST9049773235.40
131GPNMB levelsGCST9046939335.29
132Neutrophil countGCST9000239835.26
133ITGA5/VCAM1 ratioGCST9031520635.11
134ALCAM/ENPP2 ratioGCST9031323635.09
135Triglycerides in large HDLGCST9049788235.08
136Triglyceride to phosphoglyceride ratioGCST9049999234.92
137Other ulcerative colitisFING0000111734.83
138CES2 levelsGCST9046871934.82
139Cholesteryl Esters in Medium HDLGCST9049853234.79
140FOLR2/THY1 ratioGCST9031486734.75
141Free Cholesterol to Total Lipids in Small HDL percentageGCST9049943634.75
142AXL/CD163 ratioGCST9031341834.75
143Sleep durationGCST00383934.73
144MANF/NCK2 ratioGCST9031535934.70
145Cholesterol in Medium HDLGCST9049849234.57
146CD83/LAMP3 ratioGCST9031390634.43
147Concentration of large HDL particlesGCST9049782834.41
148Sum basophil neutrophil countsGCST00462034.34
149MMP9/OSM ratioGCST9031546834.33
150Blood cell traits latent factor 7 (white cell)GCST9055924934.27
151Neutrophil countGCST00462934.24
152CD300E/CD59 ratioGCST9031379434.22
153monocyte (fraction, mean, inv-norm transformed)GCST9047551134.19
154ALCAM/LRRC25 ratioGCST9031323934.17
155TIMD4 levelsGCST9047086634.13
156MMP9/OLR1 ratioGCST9031546733.92
157PLTP levelsGCST9047026233.79
158Phospholipids in IDLGCST9049762833.65
159FOLR3 levelsGCST9046926133.64
160Radial styloid tenosynovitis [de Quervain]FING0000123733.62
161CD74/TIMD4 ratioGCST9031389633.60
162PLXNA4/SKAP2 ratioGCST9031568533.58
163Free cholesterol in small HDLGCST9049942533.53
164Average diameter for HDL particlesGCST9009282833.53
165FOLR2/HAVCR2 ratioGCST9031486533.41
166Total lipids in large HDLGCST9049781533.34
167ADA2/COMP ratioGCST9031316633.31
168B3GNT7 levelsGCST9046841133.28
169CA6/DNER ratioGCST9031359433.28
170CD69/SNAP29 ratioGCST9031388733.23
171FN1 levelsGCST9046925533.18
172Granulocyte countGCST00461433.17
173LAT/SPARC ratioGCST9031528833.16
174Phospholipids to total lipids in small LDL percentage (UKB data field 23624)GCST9026972133.15
175Phosphoglycerides levelsGCST9049926533.13
176CD83 levelsGCST9046865233.12
177Total Lipids in HDLGCST9049739333.05
178Monounsaturated fatty acid levelsGCST9050203833.04
179NELL2 levelsGCST9047002733.01
180ITGAM levelsGCST9046963833.01
181UFC1 levelsGCST9024324532.99
182NOMO1 levelsGCST9047006032.97
183Sum neutrophil eosinophil countsGCST00461332.96
184ATF6 levelsGCST9061726032.96
185MMP9 levelsGCST9046992332.94
186Average diameter for VLDL particlesGCST9009300232.93
187TNFRSF1A/TNFRSF1B ratioGCST9031593732.82
188High-density lipoprotein levels (MTAG)GCST9017914732.74
189Concentration of medium HDL particlesGCST9049862232.72
190FOLR2/MSR1 ratioGCST9031486632.65
191APCS levelsGCST9042846332.63
192LRP1 levelsGCST9046979732.60
193CD163/ICAM1 ratioGCST9031373532.60
194Neutrophill count | Blood countUKBB0000049732.54
195PLA2G4A/SDC4 ratioGCST9031566832.54
196Chronic sputum productionGCST9026990232.47
197Phospholipids in large VLDLGCST9049824732.46
198EREG/MPIG6B ratioGCST9031470432.46
199Phospholipids to total lipids ratio in large LDLGCST9009286532.35
200NTRK2 levelsGCST9047009732.31
201Cholesteryl ester levels in large HDLGCST9009284632.18
202NUDT5/RWDD1 ratioGCST9031558032.18
203AXL/MCAM ratioGCST9031342132.16
204Monounsaturated fatty acid levelsGCST9050236232.15
205Cholesterol levels in large HDLGCST9009284432.11
206Free cholesterol in medium HDLGCST9049856232.11
207CFI levelsGCST9046873032.06
208Granulocyte percentage of myeloid white cellsGCST00460831.98
209Phospholipids in very small VLDLGCST9050084031.97
210ADGRE5/NOTCH1 ratioGCST9031318131.92
211IGF2R/LGMN ratioGCST9031513131.80
212Free cholesterol levels in large HDLGCST9009284831.76
213ENPP2 levelsGCST9046911531.66
214SERPING1 levelsGCST9047060031.63
215CSF3 levelsGCST9046888631.63
216Concentration of large HDL particlesGCST9009285131.61
217Recent worrying too much about different things | AnxietyUKBB0000074631.60
218TNFRSF8/TNFRSF9 ratioGCST9031594031.44
219HPGDS levelsGCST9046947231.44
220MSR1 levelsGCST9046995031.41
221CA6 levelsGCST9046851531.38
222Total lipids in medium HDLGCST9049859731.36
223Triglycerides to Total Lipids in Very Large HDL percentageGCST9050050631.35
224PLA2G2A levelsGCST9047024731.31
225IDP dMRI TBSS ICVF Cerebral peduncle RGCST9000434131.23
226CD163/FOLR2 ratioGCST9031373431.22
227FLT1/TFPI2 ratioGCST9031485631.18
228IGF2R/RNASET2 ratioGCST9031513231.15
229UrticariaGCST9001871631.11
230total creatine kinase (maximum, inv-norm transformed)GCST9047641030.95
231Cholesteryl Esters to Total Lipids in Medium HDL percentageGCST9049855630.93
232FKBP4/FKBP5 ratioGCST9031483830.89
233Cholesterol to Total Lipids in Medium HDL percentageGCST9049851630.88
234Phospholipids in very small VLDLGCST9050085130.86
235Total lipid levels in large HDLGCST9009285030.81
236Osteoporosis, osteopenia and pathological fracture | musculoskeletalUKBB0000060030.80
237Glycoprotein acetyls levels (UKB data field 23480)GCST9026957730.79
238GAS6 levelsGCST9046930530.77
239LDLR levelsGCST9046975030.75
240ARSB levelsGCST9046836930.71
241HSPB6/SNCG ratioGCST9031509030.70
242Sphingomyelins levelsGCST9049998330.58
243CLEC4G/KDR ratioGCST9031411830.52
244Phospholipids to Total Lipids in Large HDL percentageGCST9049786330.50
245Phospholipids to Total Lipids in Very Large HDL percentageGCST9050047230.43
246CCL7 levelsGCST9046858530.32
247MMP9/PLAUR ratioGCST9031547030.31
248Triglycerides in very large HDLGCST9050048230.29
249HDL cholesterol levelsGCST9009282230.23
250LAT2/SDC4 ratioGCST9031527830.22
251COMP levelsGCST9046882730.21
252Phospholipids in HDLGCST9049743730.12
253CPB2 levelsGCST9046884030.11
254ACY1/GSTA1 ratioGCST9031316330.05
255ADGRE5/ITGB2 ratioGCST9031318030.02
256B4GAT1 levelsGCST9046841329.99
257BCAN/MOG ratioGCST9031348029.94
258Free Cholesterol to Total Lipids in Very Large HDL percentageGCST9050039829.93
259Free Cholesterol to Total Lipids in Large HDL percentageGCST9049779029.93
260CASP3/SNAP23 ratioGCST9031364429.90
261Cholesteryl Esters to Total Lipids in Small HDL percentageGCST9049940629.81
262Total lipid levels in HDLGCST9009282529.68
263Free cholesterol levels in HDLGCST9009282429.61
264Cholesterol to Total Lipids in Large HDL percentageGCST9049773029.60
265Concentration of small HDL particlesGCST9049946429.60
266DKK1/PTPN6 ratioGCST9031447829.57
267neutrophil (absolute count, minimum, inv-norm transformed)GCST9047553229.56
268ADGRE5/VCAM1 ratioGCST9031318429.54
269Other diseases of blood and blood-forming organsFING0000099829.37
270Free cholesterol in large HDLGCST9049778629.33
271Free Cholesterol to Total Lipids in Large HDL percentageGCST9049779329.32
272Average diameter for VLDL particlesGCST9050029029.21
273SUSD1/THPO ratioGCST9031589929.21
274CHIT1 levelsGCST9046874429.16
275BTN2A1/SIGLEC1 ratioGCST9031354829.14
276Average diameter for HDL particles (UKB data field 23433)GCST9026953029.12
277Cholesteryl Esters to Total Lipids in Large HDL percentageGCST9049776329.10
278Phospholipid levels in large HDLGCST9009285229.06
279PEPD levelsGCST9047020929.03
280PDGFB/PTPN6 ratioGCST9031562529.02
281Cholesterol in large HDL (UKB data field 23561)GCST9026965828.99
282Cholesterol in Large LDLGCST9049791928.97
283Cholesteryl esters in large HDL (UKB data field 23562)GCST9026965928.91
284Phospholipid levels in very large HDLGCST9009301228.91
285HDL cholesterol levels (UKB data field 23406)GCST9026950328.82
286HEG1 levelsGCST9046944428.78
287HDL cholesterol | Blood biochemistryUKBB0000030628.71
288Concentration of very large HDL particlesGCST9050043628.68
289Average diameter for VLDL particles (UKB data field 23431)GCST9026952828.55
290Cholesterol to Total Lipids in Small HDL percentageGCST9049937328.52
291Glycoprotein acetyls levelsGCST9049732028.52
292Total protein levelsGCST9001875628.45
293Total lipids in medium HDLGCST9049860428.45
294monocyte (fraction, maximum, inv-norm transformed)GCST9047550828.43
295Ratio of triglycerides to phosphoglyceridesGCST9009298328.41
296Total lipid levels in very large HDLGCST9009301028.38
297FAM20A levelsGCST9046918528.33
298Cholesteryl ester levels in HDLGCST9009282328.30
299PSG1 levelsGCST9047035328.27
300Average diameter for HDL particlesGCST9049745428.17
301FOLR2 levelsGCST9046926028.15
302MAN1A2 levelsGCST9046984328.13
303Triglyceride to HDL cholesterol ratioGCST9029594928.12
304Phospholipids in large VLDL (UKB data field 23497)GCST9026959428.07
305DPP6 levelsGCST9046903427.95
306Concentration of large HDL particles (UKB data field 23558)GCST9026965527.92
307Triglycerides in small HDLGCST9049951927.87
308COMP/DPP4 ratioGCST9031418827.87
309Cake icing likingGCST9009472327.82
310Monocyte percentage (UKB data field 30190)GCST9046809127.82
311CD163 levelsGCST9046860027.71
312LAT/PDGFA ratioGCST9031528527.69
313GALNT7 levelsGCST9046929927.68
314Cholesterol in small HDL (UKB data field 23575)GCST9026967227.66
315Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST9050215527.63
316APOA1 levelsGCST9009280827.63
317PSAP levelsGCST9047035127.60
318Cholesteryl esters in HDL (UKB data field 23418)GCST9026951527.59
319Triglyceride levels in large VLDLGCST9009287827.56
320Total lipids in large HDL (UKB data field 23559)GCST9026965627.50
321PLA2G7 levelsGCST9047024927.46
322Triglycerides in large VLDL (UKB data field 23501)GCST9026959827.46
323Phospholipids to Total Lipids in Very Large HDL percentageGCST9050047427.45
324triglyceride (mean, inv-norm transformed)GCST9047643327.40
325Triglycerides in medium VLDL (UKB data field 23508)GCST9026960527.39
326Alkenylphosphatidylcholine (P-16:0/16:0) levelsGCST9002556327.33
327Free cholesterol levels in medium HDLGCST9009289627.25
328Cholesteryl ester levels in very large HDLGCST9009300627.25
329Concentration of HDL particlesGCST9009282627.23
330Total esterified cholesterol levelsGCST9050003627.21
331Free cholesterol in medium HDLGCST9049856327.15
332ALCAM/MSR1 ratioGCST9031324027.15
333High density lipoprotein cholesterol levelsGCST9027863527.03
334Monocyte countGCST9002595027.00
335Cholesteryl esters in small HDL (UKB data field 23576)GCST9026967326.98
336APOE levelsGCST9046833826.96
337Cholesterol esters in very large HDLGCST9050035426.89
338SDC4/SMAD1 ratioGCST9031582026.86
339Monounsaturated fatty acids to total fatty acids percentageGCST9050238826.84
340AGRP levelsGCST9001206326.84
341CD300C/NBL1 ratioGCST9031379226.77
342SKAP2/VSIR ratioGCST9031584926.74
343CST3/DEFA1_DEFA1B ratioGCST9031429126.73
344Myeloid white cell countGCST00462626.72
345CTSO/IGF2R ratioGCST9031431726.70
346C1QTNF5 levelsGCST9046848926.70
347ADA levelsGCST9046823126.67
348BAIAP2 levelsGCST9046841926.66
349Insomnia (weighted GWA)GCST9026728726.63
350DMP1 levelsGCST9046900726.62
351IGF2R levelsGCST9046952626.58
352Monocyte countGCST9000239326.58
353CD163/IL18BP ratioGCST9031373626.56
354KLK7 levelsGCST9046970626.52
355Concentration of very large HDL particlesGCST9009301126.51
356C-reactive protein levels (UKB data field 30710)GCST9046806426.41
357CCN2/TPP1 ratioGCST9031371826.37
358Free cholesterol to total lipids ratio in very large HDLGCST9009300926.35
359Monocyte percentage of white cellsGCST9000239426.22
360Triglycerides to Total Lipids in Large HDL percentageGCST9049789626.20
361Concentration of large VLDL particles (UKB data field 23495)GCST9026959226.15
362VAT1 levelsGCST9047102926.15
363LAT2/MANF ratioGCST9031527726.11
364Average diameter for VLDL particlesGCST9050027925.99
365Monounsaturated fatty acids to total fatty acids percentageGCST9050205125.98
366NRCAM levelsGCST9047008225.97
367Total lipids in small HDL (UKB data field 23573)GCST9026967025.95
368Glycoprotein acetyls levelsGCST9049732825.94
369Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDLGCST9009304525.90
370Total concentration of lipoprotein particles (UKB data field 23427)GCST9026952425.88
371Free cholesterol in large HDL (UKB data field 23563)GCST9026966025.88
372Phosphatidylcholine_40:6_[M+H]1+/Phosphatidylethanolamine_43:6_[M+H]1+ levelsGCST9006044625.84
373Polyunsaturated fatty acids to total fatty acids percentageGCST9049930225.79
374Free cholesterol in HDL (UKB data field 23422)GCST9026951925.75
375LCP1 levelsGCST9046974825.74
376Free cholesterol in small HDL (UKB data field 23577)GCST9026967425.74
377LRG1 levelsGCST9046979325.73
378LTB4R levelsGCST9042216425.72
379Phospholipids in small LDLGCST9049967325.63
380Total lipids in large VLDL (UKB data field 23496)GCST9026959325.59
381Triglyceride levels in medium VLDLGCST9009292625.58
382Concentration of small HDL particles (UKB data field 23572)GCST9026966925.57
383LILRA2 levelsGCST9046977125.55
384IL6ST/MARCO ratioGCST9031516725.52
385CCL18/RARRES2 ratioGCST9031369025.51
386LILRB2 levelsGCST9046977725.49
387T1 FreeSurfer a2009s lh G precentral volumeGCST9038484425.47
388CD207 levelsGCST9046860725.46
389AXL/GAS6 ratioGCST9031341925.42
390Total lipids in HDL (UKB data field 23426)GCST9026952325.41
391HDL cholesterolGCST00222325.39
392FAP/LRRN1 ratioGCST9031478325.38
393Total lipids in very large HDLGCST9050041025.32
394White blood cell countGCST9000237425.29
395DAB2/NCK2 ratioGCST9031436725.26
396SOD2 levelsGCST9047070525.21
397Phospholipids in small LDLGCST9049968125.18
398IDP SWI T2star right putamenGCST9000386825.18
399ITIH3 levelsGCST9046965025.17
400CLEC4A levelsGCST9046877125.16
401Neutrophil countGCST9002597725.16
402total creatine kinase (mean, inv-norm transformed)GCST9047641325.15
403LYVE1 levelsGCST9046983225.14
404Cholesterol levels in very large HDLGCST9009300425.13
405CLEC1B/VSIR ratioGCST9031410625.13
406Concentration of HDL particles (UKB data field 23430)GCST9026952725.13
407APOA levelsUKBB0000004025.12
408CD300LG/TNFRSF1A ratioGCST9031380325.07
409OSM levelsGCST9047013325.07
410Monocyte percentage of white cellsGCST00460925.05
411PINLYP levelsGCST9047023825.02
412Cholesteryl Esters to Total Lipids in Very Large HDL percentageGCST9050035925.00
413Phospholipids in medium LDLGCST9049883224.98
414SIGLEC5 levelsGCST9047063324.93
415AXL/VCAM1 ratioGCST9031342324.93
416Clonal hematopoiesis (large clone)GCST9010262124.91
417Cholesterol levels in small HDLGCST9009294424.89
418Osteoporosis NOS | musculoskeletalUKBB0000059924.88
419Phospholipids in large VLDLGCST9049824324.88
420Phospholipid levels in large VLDLGCST9009287624.86
421GSTA1/RBP5 ratioGCST9031499524.84
422Total cholesterol levelsGCST9050001524.84
423Total concentration of lipoprotein particlesGCST9009299024.82
424Free cholesterol levels in small HDLGCST9009294824.81
425Cholesteryl ester levels in small HDLGCST9009294624.80
426NCAM2 levelsGCST9047000424.77
427Concentration of very large VLDL particles (UKB data field 23488)GCST9026958524.75
428Cholesterol in Medium HDLGCST9049849524.72
429Dysmenorrheic pain severityGCST00665624.71
430Phospholipids in IDLGCST9049762624.69
431Plasma 16a-hydroxy DHEA 3-sulfate levels in chronic kidney diseaseGCST9026432824.69
432Free cholesterol in large VLDL (UKB data field 23500)GCST9026959724.68
433Monocyte count (UKB data field 30130)GCST9046809024.61
434IDP dMRI TBSS L1 Cingulum cingulate gyrus RGCST9000410924.60
435Lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) levelsGCST9020009824.56
436CD33 levelsGCST9046862524.48
437GSTA1 levelsGCST9046941124.44
438Osteoporosis | musculoskeletalUKBB0000059824.42
439Average diameter for LDL particlesGCST9049845824.38
440GFRA2 levelsGCST9046932924.32
441KLK8 levelsGCST9042231624.32
442Benign neoplasm of other and unspecified endocrine glandsFING0000015924.31
443Cholesterol to Total Lipids in Very Large HDL percentageGCST9050032424.31
444KAZALD1 levelsGCST9046966524.30
445Total fatty acid levelsGCST9050272624.29
446NCS1 levelsGCST9047001124.28
447Neutrophil percentage of white cellsGCST9000239924.23
448LAT/SERPINE1 ratioGCST9031528724.21
449MAD1L1/POLR2F ratioGCST9031535424.21
450Linoleic acid to total fatty acids percentageGCST9049832124.20
451Monocyte percentage | Blood countUKBB0000048024.20
452Orange juice likingGCST9009480624.19
453MANF/PDGFB ratioGCST9031536024.17
454Total lipids in very large HDLGCST9050042324.06
455Triglyceride levels in very large VLDLGCST9009302624.05
456Phospholipid levels in HDLGCST9009282723.98
457Phospholipids in large HDL (UKB data field 23560)GCST9026965723.94
458HAVCR2/TNFRSF1B ratioGCST9031503023.90
459Monounsaturated fatty acid levelsGCST9049909423.88
460ADA2 levelsGCST9046821523.86
461Triglycerides to phosphoglycerides ratio (UKB data field 23435)GCST9026953223.85
462CLEC4M levelsGCST9046877523.81
463Alzheimer's diseaseGCST9002715823.78
464white blood cell count (WBC, minimum, inv-norm transformed)GCST9047645723.76
465Concentration of large VLDL particlesGCST9009287523.72
466KLK8 levelsGCST9042549223.72
467IL6 levelsGCST9046960423.71
468APCS levelsGCST9046832823.70
469Phospholipids to total lipids ratio in IDLGCST9009284023.68
470neutrophil (absolute count, mean, inv-norm transformed)GCST9047552923.66
471Monocyte countGCST00462523.62
472LRRC25 levelsGCST9046980123.60
473MMP12 levelsGCST9046991623.60
474CST3/TAFA5 ratioGCST9031429823.58
475MARCO/SIGLEC1 ratioGCST9031538723.56
476CD22/FOLR2 ratioGCST9031375823.56
477ADIPOQ levelsGCST9046824523.52
478CTSL levelsGCST9001207323.52
479Triglycerides to Total Lipids in Small HDL percentageGCST9049953023.52
480CD163/SIGLEC1 ratioGCST9031373923.49
481CD163/MARCO ratioGCST9031373723.47
482White blood cell countGCST9000240723.44
483Total lipids in small HDLGCST9049944323.41
484Triglyceride to phosphoglyceride ratioGCST9049999623.37
485KLRB1/KLRD1 ratioGCST9031526023.36
486Phospholipids in medium HDLGCST9049864123.35
487ARTN levelsGCST9046837223.30
488CLMP/GFRA1 ratioGCST9031413323.28
489monocyte (absolute count, mean, inv-norm transformed)GCST9047550223.27
490LGALS8/SOD2 ratioGCST9031532023.23
491triglyceride (maximum, inv-norm transformed)GCST9047642923.23
492total creatine kinase (minimum, inv-norm transformed)GCST9047641623.18
493Docosahexaenoic acid to total fatty acids percentageGCST9050228123.16
494Total lipid levels in very large VLDLGCST9009302223.13
495Free cholesterol in very large HDLGCST9050038023.13
496Inflammatory bowel diseaseGCST9043218223.11
497Crohn's diseaseGCST9044679323.10
498Phospholipids in very large HDLGCST9050045823.08
499Free cholesterol levels in chylomicrons and extremely large VLDLGCST9050097523.05
500Triglycerides in very large HDLGCST9050048123.05
501APOA1 levelsGCST9046833123.04
502CSF1R levelsGCST9046888023.04
503ERBB3 levelsGCST9046914023.04
504Free cholesterol levels in very large HDLGCST9009300823.04
505CD163/MSR1 ratioGCST9031373823.03
506Triglyceride levels in VLDLGCST9009300323.02
507Androstenediol (3beta,17beta) disulfate (2) levelsGCST9019985123.01
508C-reactive protein | Blood biochemistryUKBB0000011323.01
509OLR1 levelsGCST9047012223.00
510BCAN levelsGCST9046842622.95
511CCL23 levelsGCST9046857522.94
512LRIG1 levelsGCST9046979422.92
513PDGFRB levelsGCST9047019222.90
514Triglycerides in VLDL (UKB data field 23408)GCST9026950522.90
515Total lipid levels in large VLDLGCST9009287422.90
516THPO levelsGCST9047085722.88
517VCAM1 levelsGCST9047103122.88
518Cholesterol levels in very large HDLGCST9050032222.87
519Macular cystFING0000074322.83
520CTSD levelsGCST9046891022.82
521Cholesterol esters in very large HDLGCST9050034422.80
522Concentration of very large VLDL particlesGCST9009302322.79
523ACAN levelsGCST9046819622.78
524DEFA1_DEFA1B/LCN2 ratioGCST9031445422.78
525Triglyceride levels in small VLDLGCST9009297822.77
526PCDH17/THBD ratioGCST9031560722.76
527Triglycerides to Total Lipids in Large VLDL percentageGCST9049829322.72
528Phospholipids to Total Lipids in Medium HDL percentageGCST9049865322.71
529CD59/SCARB2 ratioGCST9031385922.69
530Phospholipids to total lipids in IDL percentage (UKB data field 23609)GCST9026970622.68
531IL27 levelsGCST9046906022.67
532IDP SWI T2star left putamenGCST9000386722.66
533TYRP1 levelsGCST9047099822.65
534Phospholipids to Total Lipids in Medium HDL percentageGCST9049865122.64
535OLR1/OSM ratioGCST9031558322.61
536ISM1 levelsGCST9046963022.59
537Total lipids in very large VLDL (UKB data field 23489)GCST9026958622.59
538TEK levelsGCST9047082922.58
539White blood cell countGCST00461022.56
540TPP1 levelsGCST9047094622.55
541Concentration of large VLDL particlesGCST9049822322.53
542FHIT/MAX ratioGCST9031481822.52
543Ulcerative colitisGCST9044679522.52
544CLSTN2 levelsGCST9046878922.49
545Total lipids in very large VLDLGCST9050061422.49
546SCARB2 levelsGCST9047053522.47
547CD6/EZR ratioGCST9031389022.47
548NADK/S100A11 ratioGCST9031551322.46
549Concentration of very large VLDL particlesGCST9050063122.45
550Fruit juice likingGCST9009476822.45
551Concentration of small HDL particlesGCST9009295122.45
552Cholesteryl esters in very large HDL (UKB data field 23555)GCST9026965222.45
553Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST9050257022.45
554Total fatty acid levelsGCST9050222022.45
555Blood cell traits latent factor 1 (white cell)GCST9055924322.44
556Cholesteryl esters to total lipids in large LDL percentage (UKB data field 23616)GCST9026971322.44
557CTSO levelsGCST9046891522.44
558Follicle stimulating hormone levelsGCST9048347622.34
559Triglyceride levelsGCST9023966322.32
560Cholesterol levels in medium HDLGCST9009289222.25
561Concentration of medium HDL particlesGCST9009289922.23
562HPCAL1/LAT ratioGCST9031507222.21
563Triglycerides in large HDLGCST9049788822.21
564HSD17B14 levelsGCST9046948322.20
565F13B levelsGCST9046916722.18
566IL12B levelsGCST9046954922.14
567FOLR3/KLK8 ratioGCST9031486822.13
568MAX/STK24 ratioGCST9031540422.12
569SEZ6L levelsGCST9047060722.07
570Cholesteryl esters to total lipids in small LDL percentage (UKB data field 23626)GCST9026972322.07
571FCN1 levelsGCST9046920322.06
572Benign neoplasm of eye (PheCode 224)GCST9047562622.05
573ITGB1/ITGB2 ratioGCST9031522521.96
574SIGLEC10 levelsGCST9047063021.90
575Monounsaturated fatty acids to total fatty acids percentageGCST9050238921.86
576GRSF1 levelsGCST9046940721.82
577DPP6/SEZ6L2 ratioGCST9031454321.81
578LTBP2 levelsGCST9046981421.80
579Phospholipids in very large VLDL (UKB data field 23490)GCST9026958721.80
580Triglycerides to Total Lipids in Very Large VLDL percentageGCST9050069521.78
581Total lipids in large VLDLGCST9049821621.78
582CD248 levelsGCST9046861221.76
583Free cholesterol in medium HDL (UKB data field 23570)GCST9026966721.76
584PKD1 levelsGCST9047024021.75
585Cholesteryl ester levels in medium HDLGCST9009289421.75
586ICAM1 levelsGCST9046949821.74
587APOB/APOA1 ratioGCST9049715621.74
588neutrophil (fraction, mean, inv-norm transformed)GCST9047553821.69
589Triglyceride levels (UKB data field 30870)GCST9046810621.68
590LGALS3BP levelsGCST9046976021.66
591Basophill percentage | Blood countUKBB0000008721.66
592CCL24 levelsGCST9046857621.65
593CCL18 levelsGCST9046857021.64
594Phospholipids to Total Lipids in Large VLDL percentageGCST9049825221.53
595SIGLEC8 levelsGCST9008988621.49
596IL1RN/LGALS9 ratioGCST9031516021.43
597RETN/RNASET2 ratioGCST9031576821.42
598CD164/CD99 ratioGCST9031374021.38
599Cholesteryl Esters in Medium HDLGCST9049853821.38
600EREG/GYS1 ratioGCST9031470121.34
601Generalized epilepsyFING0000056721.34
602Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST9049928721.31
603CD83/TNFRSF4 ratioGCST9031390721.30
604CD63/CLEC1B ratioGCST9031386321.29
605Phospholipids in very large HDL (UKB data field 23553)GCST9026965021.28
606Triglycerides in medium HDLGCST9049866721.16
607Total lipid levels in lipoprotein particlesGCST9050008521.16
608IL1RL2 levelsGCST9046957521.13
609GP1BA levelsGCST9046938021.12
610Cholesteryl Esters in Large HDLGCST9049775321.03
611Monocyte count | Blood countUKBB0000047921.00
612Triglycerides to Total Lipids in Small VLDL percentageGCST9049992220.98
613NCS1/NPY ratioGCST9031552720.96
614IDP dMRI ProbtrackX ISOVF fmiGCST9000453620.96
615APOA1 levelsGCST9026953720.92
616CD5/IL16 ratioGCST9031386120.90
617Total lipids in very large HDL (UKB data field 23552)GCST9026964920.89
618CLUL1 levelsGCST9046879220.88
619PDGFA/PLA2G4A ratioGCST9031561520.85
620Triglycerides to Total Lipids in Large VLDL percentageGCST9049828720.82
621CCL2/CCL7 ratioGCST9031369620.82
622Cholesterol levels in chylomicrons and extremely large VLDLGCST9050091820.81
623CHGA levelsGCST9024069920.79
624Triglycerides to total lipids ratio in small HDLGCST9009295520.78
625Phospholipids in very large VLDLGCST9050064420.75
626SIGLEC1 levelsGCST9047063220.74
627RELT/TNFRSF1A ratioGCST9031576720.73
628CFP levelsGCST9046873120.72
629Triglycerides in very large VLDL (UKB data field 23494)GCST9026959120.69
630ITGAM/ITGAV ratioGCST9031520920.65
631HVEM on Terminally Differentiated CD4+ T cellGCST9000187920.64
632Cholesterol in Small LDLGCST9049955520.58
633Cholesterol in Large HDLGCST9049771920.57
634Total lipid levels in medium HDLGCST9009289820.57
635Cholesterol in Medium LDLGCST9049870320.56
636Phospholipids to Total Lipids in Very Large VLDL percentageGCST9050066520.56
637White blood cell (leukocyte) count | Blood countUKBB0000091320.55
638Cholesterol in medium HDL (UKB data field 23568)GCST9026966520.52
639Phospholipids in HDL (UKB data field 23414)GCST9026951120.52
640Free Cholesterol to Total Lipids in Large VLDL percentageGCST9049820420.51
641THBS4 levelsGCST9047085520.51
642DNAJA2/PRDX5 ratioGCST9031450620.50
643DCN levelsGCST9046895620.49
644Cholesteryl esters in medium HDL (UKB data field 23569)GCST9026966620.47
645ADH4/SORD ratioGCST9031319620.39
646Phospholipid levels in very large VLDLGCST9009302420.39
647Alzheimer's disease or family history of Alzheimer's diseaseGCST9001287720.38
648PLXNB2 levelsGCST9047026620.38
649monocyte (absolute count, maximum, inv-norm transformed)GCST9047549920.37
650CTSC levelsGCST9046890920.36
651CCL13/CCL17 ratioGCST9031367420.35
652CD300E/CXCL10 ratioGCST9031379620.34
653Triglycerides in VLDLGCST9050030420.32
654PLAUR levelsGCST9047025120.30
655Phospholipids in medium HDLGCST9049863520.24
656Basophil countGCST9002599720.23
657PTX3 levelsGCST9047039220.23
658Free cholesterol levels in large VLDLGCST9009287220.23
659Phospholipids in small HDL (UKB data field 23574)GCST9026967120.22
660Triglycerides to Total Lipids in Medium VLDL percentageGCST9049906920.21
661CRIM1/NRP2 ratioGCST9031426120.18
662CTSZ/HSPG2 ratioGCST9031431820.17
663Triglyceride levels in large HDLGCST9009285420.17
664Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)GCST9026973020.14
665BGN levelsGCST9046844120.11
666Cholesterol in very large HDL (UKB data field 23554)GCST9026965120.11
667neutrophil (absolute count, maximum, inv-norm transformed)GCST9047552620.10
668ENPP5 levelsGCST9046911620.07
669IGSF3 levelsGCST9046953920.04
670Cholesterol in large VLDL (UKB data field 23498)GCST9026959520.04
671PAM levelsGCST9047015619.97
672COL1A1/OMD ratioGCST9031417119.96
673Triglycerides in large VLDLGCST9049826719.93
674CDKN1A/TMSB10 ratioGCST9031397819.91
675ITGA5/LILRA2 ratioGCST9031520419.91
676Omega-6 fatty acids to total fatty acids percentageGCST9049921019.91
677ADGRE2 levelsGCST9046823719.91
678ITGB5/SIAE ratioGCST9031523419.88
679Monounsaturated fatty acid levelsGCST9050236319.88
680Dermatophytosis of nail (PheCode 110.11)GCST9047556219.88
681Cholesteryl Esters to Total Lipids in Very Large HDL percentageGCST9050037319.84
682PRCP/SELE ratioGCST9031572619.81
683Liver condition (ex. cirrhosis)GCST9047527019.79
684AGR3 levelsGCST9046825419.79
685FIS1/PDGFB ratioGCST9031483019.77
686CLPP levelsGCST9046878519.77
687White blood cell countGCST9027864719.76
688Free cholesterol in large VLDLGCST9049818519.74
689LifespanGCST9055188519.73
690ATP5IF1/FIS1 ratioGCST9031338519.72
691Cholesterol esters in very small VLDLGCST9050074019.71
692DAPP1/SDC4 ratioGCST9031439919.71
693Triglyceride to HDL cholesterol ratioGCST9029595119.66
694Volume of left central nucleusGCST9047495819.66
695Female infertility, associated with anovulationFING0000053719.64
696Right-hemisphere dorsal attention network to pallidum white-matter structural connectivityGCST9030280919.63
697C7 levelsGCST9046850219.61
698Free cholesterol in very large VLDL (UKB data field 23493)GCST9026959019.59
699Docosahexaenoic acid levelsGCST9050198419.55
700Total lipids in small HDLGCST9049945619.55
701VNN2 levelsGCST9047104419.53
702Phospholipid levels in medium HDLGCST9009290019.52
703Triglycerides in very large VLDLGCST9050067119.52
704FLT4 levelsGCST9046925219.49
705CD163/DSC2 ratioGCST9031373319.47
706ITGB2 levelsGCST9046964419.43
707PRCP levelsGCST9047031419.43
708Concentration of very large HDL particles (UKB data field 23551)GCST9026964819.42
709HGF levelsGCST9046944919.42
710BPIFB1 levelsGCST9046846219.42
711Neutrophill percentage (UKB data field 30200)GCST9046809319.42
712Glycoprotein acetyls levelsGCST9009282119.40
713CD300E levelsGCST9046862119.38
714AIF1 levelsGCST9046826719.38
715CCL18/TFPI ratioGCST9031369119.38
716S100A11/S100A12 ratioGCST9031579819.38
717Linoleic acid levelsGCST9009288019.37
718OMG levelsGCST9047012419.37
719GSTA1/PBLD ratioGCST9031499419.36
720ASPN levelsGCST9046837719.34
721CD300C/MANSC1 ratioGCST9031379119.33
722MAP4K5/STAMBP ratioGCST9031538219.32
723NOTCH3/PTPRS ratioGCST9031554719.32
724Cholesterol to Total Lipids in Very Large HDL percentageGCST9050033319.29
725Nonspecific chest pain | circulatory systemUKBB0000052719.28
726CRIP2/SNCG ratioGCST9031426219.28
727CHI3L1/PRSS8 ratioGCST9031404419.27
728White blood cell countGCST9002598519.27
729KLK10 levelsGCST9046969619.27
730LAG3/VCAM1 ratioGCST9031527019.25
731CASP3/PDGFA ratioGCST9031363719.23
732Free cholesterol to total lipids ratio in medium HDLGCST9009289719.22
733Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST9050105019.21
734ADGRG2 levelsGCST9046824119.19
735GFRA1/TNFRSF1A ratioGCST9031492419.17
736DKK3 levelsGCST9046899819.15
737DNMBP/PTPN1 ratioGCST9031451719.13
738CLEC4G levelsGCST9046877419.11
739EREG/F2R ratioGCST9031470019.11
740IL12A or IL12B levelsGCST9046954819.07
741RILP/RWDD1 ratioGCST9031577819.04
742VIT levelsGCST9047104119.04
743STMN3 levelsGCST9024289419.02
744Low-density lipoprotein levels (MTAG)GCST9017914819.02
745IDP dMRI TBSS ICVF Posterior thalamic radiation RGCST9000435519.01
746neutrophil (fraction, maximum, inv-norm transformed)GCST9047553519.01
747PLA2G15 levelsGCST9047024518.99
748Triglycerides in very small VLDLGCST9050088518.96
749Cholesteryl esters in chylomicrons and extremely large VLDL (UKB data field 23485)GCST9026958218.92
750VMO1 levelsGCST9047104218.91
751Total free cholesterol levelsGCST9050006318.91
752NELL2/SEZ6L ratioGCST9031553618.89
753CLEC5A levelsGCST9046877618.87
754IDP dMRI ProbtrackX ICVF ptr lGCST9000439418.85
755Total lipids in large VLDLGCST9049820718.82
756Mucosal proctocolitisFING0000084118.82
757CFB levelsGCST9046872318.81
758Triglyceride levels in very large HDLGCST9009301418.81
759IDP dMRI ProbtrackX ISOVF unc lGCST9000455018.80
760RHOC/TBCB ratioGCST9031577418.78
761Total triglycerides levelsGCST9009299218.76
762PTP4A3 levelsGCST9047037518.75
763APOD levelsGCST9046833718.73
764CPE levelsGCST9046884118.73
765VSIG4 levelsGCST9047105218.72
766Triglycerides in small VLDL (UKB data field 23515)GCST9026961218.71
767Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST9050095818.71
768B4GALT1/IFNGR1 ratioGCST9031343018.71
769Neutrophil percentage of white cellsGCST00463318.66
770Phospholipids to total lipids in very small VLDL percentage (UKB data field 23604)GCST9026970118.66
771CTSB levelsGCST9046890818.64
772GALNT10 levelsGCST9046929518.64
773ALB levelsGCST9027861618.63
774TMPRSS15 levelsGCST9047089218.63
775IL12B levelsGCST9027479818.61
776Dermatophytosis (PheCode 110.1)GCST9047556118.60
777Saturated fatty acids to total fatty acids percentageGCST9049996618.58
778Free cholesterol to total lipids in medium HDL percentage (UKB data field 23642)GCST9026973918.56
779FBLN2 levelsGCST9046919318.51
780STK24/TDRKH ratioGCST9031589318.50
781Phospholipids in large LDLGCST9049805318.49
782Triglyceride levels in small LDLGCST9009296618.44
783Triglycerides to Total Lipids in Small HDL percentageGCST9049954318.41
784CR1 levelsGCST9046885118.41
785Triglycerides to Total Lipids in Very Large VLDL percentageGCST9050069218.39
786L1CAM levelsGCST9046972318.38
787CFB levelsGCST9024077818.35
788Total Alkenylphosphatidylcholine levelsGCST9002583518.33
789Docosahexaenoic acid to total fatty acids percentageGCST9049727018.28
790Concentration of medium HDL particles (UKB data field 23565)GCST9026966218.28
791Triglycerides to total lipids ratio in very large HDLGCST9009301518.26
792MERTK levelsGCST9046989018.26
793ADGRE1 levelsGCST9046823618.23
794CD5/CD6 ratioGCST9031386018.22
795CLEC4G/NELL2 ratioGCST9031412218.22
796Basophil percentage of white cellsGCST9000238018.21
797Cholesterol to total lipids in large HDL percentage (UKB data field 23635)GCST9026973218.20
798ITGA11 levelsGCST9046963318.19
799CPM/PCSK9 ratioGCST9031421618.19
800Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST9050092018.18
801Gestational age at birth (maternal effect)GCST9026841918.16
802Cholesterol levels in very small VLDLGCST9050070018.16
803Cholesterol in very large VLDL (UKB data field 23491)GCST9026958818.14
804DPP4/ITGB1 ratioGCST9031454018.13
805ADGRE5 levelsGCST9046823818.12
806DTI TBSS L2 Posterior corona radiata LGCST9038450318.12
807Peptic ulcer (excl. esophageal) | digestiveUKBB0000063918.11
808SF3B4/SIRT2 ratioGCST9031583818.10
809Dermatophytosis / Dermatomycosis (PheCode 110)GCST9047556018.07
810DNAJA2/HPCAL1 ratioGCST9031450318.06
811ITIH3/VCAM1 ratioGCST9031523618.05
812Phospholipids to Total Lipids in Large VLDL percentageGCST9049825818.03
813Basophil countGCST9000237918.03
814Triglycerides to Total Lipids in Small VLDL percentageGCST9049993418.01
815Total lipid levels in small HDLGCST9009295018.00
816CXCL14 levelsGCST9046892717.98
817Triglycerides to Total Lipids in Small LDL percentageGCST9049974017.97
818IDP T1 FAST ROIs R ventral striatumGCST9000256017.95
819F3/GFRA1 ratioGCST9031474117.93
820CA4/FOLR2 ratioGCST9031358517.93
821Takes medication for blood clot/ pulmonary embolism/ deep vein thrombosis (DVT)?GCST9047521017.92
822Cholesteryl Esters in Large VLDLGCST9049814617.89
823Phospholipids to total lipids ratio in small LDLGCST9009296517.89
824Spleen iron concentrationGCST9010183117.88
825Phospholipids to total lipids in large LDL percentage (UKB data field 23614)GCST9026971117.86
826Cholesteryl esters in very large VLDL (UKB data field 23492)GCST9026958917.81
827GOLM2 levelsGCST9046937617.81
828Cholesterol to Total Lipids in Medium LDL percentageGCST9049871417.80
829Free Cholesterol to Total Lipids in Very Large VLDL percentageGCST9050059817.78
830Mouth/teeth dental problems - Mouth ulcers | MouthUKBB0000048817.75
831IL16 levelsGCST9046955717.75
832Docosahexaenoic acid levelsGCST9049725617.73
833Pregnenediol disulfate (C21H34O8S2) levelsGCST9019984017.73
834CCN2/TACC3 ratioGCST9031371717.70
835Phospholipids to total lipids ratio in very small VLDLGCST9009303717.69
836Cholesteryl Esters to Total Lipids in Medium LDL percentageGCST9049874717.69
837EGFLAM levelsGCST9042165117.67
838Cholesteryl Esters in Medium LDLGCST9049873917.67
839GLB1/IMPA1 ratioGCST9031493217.66
840PDGFRA levelsGCST9047019117.65
841Any dementia (more control exclusions)FING0000009917.65
842Total lipids in medium HDL (UKB data field 23566)GCST9026966317.61
843Triglycerides to Total Lipids in Very Small VLDL percentageGCST9050088617.61
844Cholesterol to total lipids ratio in large HDLGCST9009284517.60
845ROBO1 levelsGCST9047048917.57
846Concentration of very large HDL particlesGCST9050043117.57
847Triglycerides to Total Lipids in Medium VLDL percentageGCST9049907317.57
848Total triglycerides levelsGCST9050012617.55
849ERBB4 levelsGCST9046914117.54
850APOC1 levelsGCST9046833617.54
851aparc-a2009s rh volume G+S-subcentralGCST9000300217.49
852Free cholesterol to total lipids in very large HDL percentage (UKB data field 23632)GCST9026972917.49
853Total triglycerides levels (UKB data field 23407)GCST9026950417.48
854CLEC10A levelsGCST9046876317.47
855Phospholipids to total lipids ratio in large HDLGCST9009285317.44
856Free cholesterol levels in very large VLDLGCST9009302017.44
857MPHOSPH8/PSRC1 ratioGCST9031547817.42
858Triglycerides to Total Lipids in Medium LDL percentageGCST9049888517.42
859Total protein levelsGCST9002599517.41
860Cholesteryl Esters in Small LDLGCST9049957817.40
861Docosahexaenoic acid levelsGCST9050225517.39
862IDP dMRI ProbtrackX ICVF ptr rGCST9000439517.38
863CD300A levelsGCST9046861917.37
864Cholesteryl ester levels in chylomicrons and extremely large VLDLGCST9009304217.37
865EIF1AX levelsGCST9024112017.36
866METAP2/RILP ratioGCST9031543317.35
867LDLR/PCSK9 ratioGCST9031531117.34
868Strawberries likingGCST9009484917.33
869Benign neoplasm of eye, uveal (PheCode 224.1)GCST9047562917.30
870Superficial cellulitis and abscess (PheCode 681)GCST9047616517.30
871EREG levelsGCST9046914517.28
872Free cholesterol to total lipids ratio in large LDLGCST9009286117.26
873SIGLEC6 levelsGCST9047063417.26
874Total fatty acid levelsGCST9050006117.25
875CEACAM8/MMP9 ratioGCST9031400217.24
876CXCL10 levelsGCST9027478017.23
877ANXA4/LACTB2 ratioGCST9031329317.20
878TCN1 levelsGCST9047081917.18
879Other specified diseases of sebaceous glands (PheCode 706.8)GCST9047621517.15
880WFIKKN2 levelsGCST9047107717.13
881S100A13 levelsGCST9047051417.12
882PMVK/PRDX5 ratioGCST9031569417.09
883CD300E/EFNA4 ratioGCST9031379717.08
884Docosahexaenoic acid to total fatty acids percentageGCST9050199717.07
885ENG/TNFSF10 ratioGCST9031465117.06
886aseg lh volume Cerebellum-White-MatterGCST9000261817.05
887TNFSF13 levelsGCST9047092117.04
888Free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23582)GCST9026967917.03
889CD164/NUDT5 ratioGCST9031374217.02
890aseg lh intensity CaudateGCST9000376917.01
891VEGFD levelsGCST9047103716.99
892APLP1 levelsGCST9046833016.99
893Triglycerides x depression interaction (2df test)GCST9057067916.97
894IFIT2 levelsGCST9009086416.97
895MPIG6B/PDGFB ratioGCST9031548216.96
896Cholesterol levels in large VLDLGCST9009286816.96
897Phosphatidylcholine levelsGCST9009293716.94
898Alzheimer's disease (late onset)GCST00224516.91
899CNST/DOK2 ratioGCST9031415716.90
900Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST9050098316.89
901neutrophil (fraction, minimum, inv-norm transformed)GCST9047554116.88
902CANT1/GSTA1 ratioGCST9031361616.88
903FURIN levelsGCST9046927716.87
904Other follicular disordersFING0000105016.86
905Basophil countGCST9000229216.86
906KLRD1/LY9 ratioGCST9031526116.85
907MXRA8 levelsGCST9046996816.84
908IDS/SMPDL3A ratioGCST9031512616.84
909Phospholipids to total lipids in large HDL percentage (UKB data field 23634)GCST9026973116.82
910Total Lipids in Medium LDLGCST9049880616.81
911Volume of left central nucleusGCST9047488316.79
912CCL5/TACC3 ratioGCST9031370716.78
913PLA2G4A/SPINT2 ratioGCST9031567116.77
914Sleep duration | SleepUKBB0000077716.74
915DAPK2 levelsGCST9046894516.71
916Free cholesterol in medium VLDLGCST9049896516.68
917FCGR2A/FCGR2B ratioGCST9031479316.67
918Concentration of chylomicrons and extremely large VLDL particlesGCST9050101516.67
919SORT1/VSIR ratioGCST9031587016.63
920Concentration of large VLDL particlesGCST9049822616.63
921Total lipids in very large VLDLGCST9050060716.55
922CD300C/CLEC14A ratioGCST9031378616.54
923IDP dMRI TBSS ICVF Posterior thalamic radiation LGCST9000435616.53
924Left-hemisphere control network to accumbens white-matter structural connectivityGCST9030275816.52
925Phospholipids to Total Lipids in Small HDL percentageGCST9049949416.51
926MET levelsGCST9046989516.50
927DKK1/MGLL ratioGCST9031447316.50
928CD300LG/CLEC14A ratioGCST9031380116.49
929DARS1/USP8 ratioGCST9031440716.48
930CD200R1/CLEC4G ratioGCST9031374816.47
931Free cholesterol in very large VLDLGCST9050057516.47
932FAP levelsGCST9046918916.46
933Cholesteryl Esters in Small LDLGCST9049958616.45
934PTPN6/SNAP23 ratioGCST9031574716.39
935EGLN1/LSP1 ratioGCST9031461716.38
936IDP SWI T2star right pallidumGCST9000387016.38
937Metabolic syndromeGCST00960216.34
938ST6GAL1 levelsGCST9047075316.31
939Free cholesterol in medium LDLGCST9049877416.29
940MANF/SDC4 ratioGCST9031536716.24
941Concentration of very large VLDL particlesGCST9050062816.23
942RNASET2 levelsGCST9047048116.23
943Triglycerides to Total Lipids in Small LDL percentageGCST9049972616.22
944Free Cholesterol to Total Lipids in Large VLDL percentageGCST9049819916.22
945LAG3 levelsGCST9046972716.21
946Cholesterol in chylomicrons and extremely large VLDL (UKB data field 23484)GCST9026958116.21
947SCLY/SORD ratioGCST9031581616.20
948Depression (broad)GCST00590216.20
949Neutrophill percentage | Blood countUKBB0000049816.20
950ENTPD5 levelsGCST9046912116.20
951QSOX1 levelsGCST9047040216.17
952Total cholines levelsGCST9009281216.17
953ADH4/KYNU ratioGCST9031319316.16
954DNAJA2/FIS1 ratioGCST9031450116.14
955Triglycerides in medium VLDLGCST9049906516.13
956Linoleic acid levels (UKB data field 23449)GCST9026954616.13
957CD4 levelsGCST9046863616.11
958Phosphoglycerides levelsGCST9009293816.11
959DNAJA2/HCLS1 ratioGCST9031450216.10
960Phospholipids to Total Lipids in Medium LDL percentageGCST9049885216.09
961SERPINE1/SMAD1 ratioGCST9031583316.09
962ERP29 levelsGCST9008884316.07
963Triglycerides to Total Lipids in Medium LDL percentageGCST9049888116.07
964ACVRL1/SCARB2 ratioGCST9031315716.05
965CRKL/SERPINB1 ratioGCST9031427216.05
966Cholesterol in Medium VLDLGCST9049890316.03
967ITGB6 levelsGCST9046964616.02
968IL6ST/PDGFRA ratioGCST9031516916.01
969Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST9050257115.97
970Alzheimer's disease or family history of Alzheimer's diseaseGCST00732015.94
971CD209 levelsGCST9046860815.94
972Triglyceride levels in small HDLGCST9009295415.94
973HDL x depression interaction (2df test)GCST9057066715.93
974IDP dMRI TBSS ICVF Posterior limb of internal capsule LGCST9000434615.92
975AXL levelsGCST9046840615.91
976FCGR2B/NOS3 ratioGCST9031479415.90
977Squamous cell carcinoma (MTAG)GCST9013741215.89
978ESM1 levelsGCST9046915315.87
979Cholesterol levels in very large VLDLGCST9050051815.87
980Monounsaturated fatty acid levelsGCST9009292815.85
981Glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) levelsGCST9020010515.85
982Cholesteryl Esters in Medium VLDLGCST9049893915.84
983Free cholesterol levels in chylomicrons and extremely large VLDLGCST9050096515.84
984CRTAM/KLRD1 ratioGCST9031427715.84
985Osteomyelitis, periostitis, and other infections involving bone (PheCode 710)GCST9047622015.83
986Saturated fatty acids levelsGCST9050265815.82
987IFNAR1 levelsGCST9046951215.82
988TAX1BP3 levelsGCST9024297615.80
989CFHR2 levelsGCST9046872615.80
990Free cholesterol in very large HDL (UKB data field 23556)GCST9026965315.79
991Cholesterol levels in very large VLDLGCST9009301615.79
992IDO1 levelsGCST9046950615.78
993AmygNuclei lh volume Central-nucleusGCST9000265215.77
994Total lipids in medium VLDLGCST9049900415.75
995Ulcerative rectosigmoiditisFING0000139415.75
996SEMA3F levelsGCST9047057015.75
997Allergic rhinitisGCST9008604215.74
998Phospholipids in medium VLDLGCST9049902415.73
999STAB2 levelsGCST9047075515.70
1000Physical activity (Total log acceleration 6pm-8pm)GCST9006141815.70